Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc.verified

XERS

Price:

$2.51

Market Cap:

$373.99M

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its pr...[Read more]

Industry

Biotechnology

IPO Date

2018-06-21

Stock Exchange

NASDAQ

Ticker

XERS

The Dividend Yield as of September 2024 (TTM) for Xeris Biopharma Holdings, Inc. (XERS) is 0%

According to Xeris Biopharma Holdings, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Xeris Biopharma Holdings, Inc. (XERS) Historical Dividend Yield (quarterly & annually)

How has XERS Dividend Yield performed in the past?

The mean historical Dividend Yield of Xeris Biopharma Holdings, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), XERS's Dividend Yield was at its highest in in the March 2017 quarter at 0%. The Dividend Yield was at its lowest in in the March 2017 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Xeris Biopharma Holdings, Inc. (XERS) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Xeris Biopharma Holdings, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%

Xeris Biopharma Holdings, Inc. (XERS) Average Dividend Yield

How has XERS Dividend Yield performed in the past?

The current Dividend Yield of Xeris Biopharma Holdings, Inc. (XERS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Xeris Biopharma Holdings, Inc. (XERS) Dividend Yield vs. Peers

How is XERS’s Dividend Yield compared to its peers?

Xeris Biopharma Holdings, Inc.’s Dividend Yield is less than Protalix BioTherapeutics, Inc. (0%), less than Seres Therapeutics, Inc. (0%), less than Cidara Therapeutics, Inc. (0%), less than ImmunityBio, Inc. (0%), less than Galera Therapeutics, Inc. (0%), less than Mereo BioPharma Group plc (0%), less than Terns Pharmaceuticals, Inc. (0%), less than PDS Biotechnology Corporation (0%), less than Inozyme Pharma, Inc. (0%), less than HOOKIPA Pharma Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than eFFECTOR Therapeutics, Inc. (0%), less than Elevation Oncology, Inc. (0%), less than Hepion Pharmaceuticals, Inc. (0%),

Build a custom stock screener for Xeris Biopharma Holdings, Inc. (XERS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xeris Biopharma Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xeris Biopharma Holdings, Inc. (XERS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xeris Biopharma Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Xeris Biopharma Holdings, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Xeris Biopharma Holdings, Inc. (XERS)?

What is the highest Dividend Yield for Xeris Biopharma Holdings, Inc. (XERS)?

What is the 3-year average Dividend Yield for Xeris Biopharma Holdings, Inc. (XERS)?

What is the 5-year average Dividend Yield for Xeris Biopharma Holdings, Inc. (XERS)?

How does the current Dividend Yield for Xeris Biopharma Holdings, Inc. (XERS) compare to its historical average?